AbCellera to Participate at Upcoming Investor Conferences in September

Audio By Carbonatix

VANCOUVER, British Columbia--(BUSINESS WIRE)--Aug 12, 2025--

AbCellera (Nasdaq: ABCL) today announced that the Company will participate in the following investor conferences:

• Wells Fargo Healthcare Conference, September 3-5, 2025
• Morgan Stanley Annual Global Healthcare Conference, September 8-10, 2025

Visit AbCellera's Investor Relations website for additional information.

About AbCellera Biologics Inc.

AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women's health, immunology, and oncology. For more information, please visit www.abcellera.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20250812333835/en/

CONTACT: Inquiries

Media: Tiffany Chiu;[email protected], +1(236)521-6774

Partnering: Murray McCutcheon, Ph.D.;[email protected], +1(604)559-9005

Investor Relations: Peter Ahn;[email protected], +1(778)729-9116

KEYWORD: NORTH AMERICA CANADA

INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH PHARMACEUTICAL MANAGED CARE ONCOLOGY

SOURCE: AbCellera Biologics Inc.

Copyright Business Wire 2025.

PUB: 08/12/2025 04:05 PM/DISC: 08/12/2025 04:06 PM

http://www.businesswire.com/news/home/20250812333835/en